Effect of GLP-1 Receptor Agonist, Exenatide on Glucosuria Induced Elevation in ENDOGENOUS GLUCOSE PRODUCTION (EGP)
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2018
At a glance
- Drugs Dapagliflozin (Primary) ; Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 19 Feb 2018 Status changed from not yet recruiting to recruiting.
- 04 Dec 2017 Planned End Date changed from 1 Jan 2019 to 31 Jan 2020.
- 04 Dec 2017 Planned primary completion date changed from 1 Jan 2019 to 31 Jan 2019.